BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 84 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,164,000 | +2.6% | 20,443 | -3.6% | 0.03% | 0.0% |
| Q3 2019 | $1,135,000 | -19.0% | 21,213 | -9.7% | 0.03% | -18.8% |
| Q2 2019 | $1,402,000 | +125.8% | 23,488 | +135.6% | 0.03% | +128.6% |
| Q1 2019 | $621,000 | +2.8% | 9,968 | 0.0% | 0.01% | -6.7% |
| Q4 2018 | $604,000 | -9.0% | 9,968 | -34.9% | 0.02% | 0.0% |
| Q4 2017 | $664,000 | -6.9% | 15,316 | 0.0% | 0.02% | -6.2% |
| Q3 2017 | $713,000 | -5.9% | 15,316 | 0.0% | 0.02% | -5.9% |
| Q2 2017 | $758,000 | +58.2% | 15,316 | +75.1% | 0.02% | +54.5% |
| Q1 2017 | $479,000 | -1.6% | 8,749 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $487,000 | +21.8% | 8,749 | 0.0% | 0.01% | +22.2% |
| Q3 2016 | $400,000 | +14.6% | 8,749 | 0.0% | 0.01% | +12.5% |
| Q2 2016 | $349,000 | +58.6% | 8,749 | +71.1% | 0.01% | +60.0% |
| Q4 2015 | $220,000 | -1.3% | 5,113 | 0.0% | 0.01% | -16.7% |
| Q3 2015 | $223,000 | – | 5,113 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |